Phase 3 N=28 Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix
Cervical Squamous Cell Carcinoma · Adenosquamous Carcinoma · Adenocarcinoma
Primary: Overall Survival Rate
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=40 Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia
AML
Primary: Complete Response Rate — 19 Participants
Phase 4 N=385 Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children
Pneumonia
Primary: Desirability of Outcome Ranking (DOOR) — 97; 107; 47; 42 Participants — p=<0.001
N/A N=46 Neurophysiological and Kinematic Predictors of Response in Chronic Stroke
Stroke
Primary: Stroke Impact Scale: Hand — 20.4; 22.2; 30.0 score on a scale
Phase 3 N=795 A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Rhinitis, Allergic, Seasonal
Primary: Mean Change From Baseline in Reflective Total Nasal Symptom Score (rTNSS) (Equivalence: Per-Protocol Population) — 1.981; 1.817 score on scale
Phase 2 N=20 A Study to Evaluate the Effect of Gefapixant (AF-219/MK-7264) on Methacholine Hyper-reactivity in Participants With Asthma (MK-7264-009)
Asthma
Primary: Provocative Concentration (PC20) After Methacholine Challenge — 0.91; 0.84; 0.82 log [mg/mL] — p=0.616
N/A N=11 Trilogy Comparison Study - Adults
Respiratory Insufficiency · Respiratory Failure
Primary: Comparable Level of Gas Exchange (Measured as Partial Pressure of CO2 in Arterial or Venous Blood). — 42; 43 mm Hg
N/A N=58 Study of an Expandable Interbody Device for the Lumbar Spine
Degenerative Disc Disease
Primary: Fusion and Disc Height Maintenance — 11.60 millimetres
N/A N=418 Internet Assisted Obesity Treatment Enhanced With Financial Incentives
Obesity
Primary: Weight Change — 97.8; 95.6; 4.7; 6.4 kilograms — p=<.01
Phase 2 N=14 Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors
Neoplasms · Pancreatic Neoplasms
Primary: Objective Response (OR) (Partial Responses + Complete Responses) in Phase 2 Subjects of Short Infusion LMB-100+ Nab-paclitaxel — 1 Participants
N/A N=42 Comparison of Robot-Assisted Gait Training and Conventional Therapy in Multiple Sclerosis Patients
Multiple Sclerosis
Primary: Fatigue Severity Score — 5.5; 6 score on a scale
N/A N=8 Accuracy of Non-invasive Non-oscillometric Blood Pressure Wristband
Hypotension · Hypertension
Primary: Average Error in Blood Pressure Readings — -1.5; 3.2 mmHg
N/A N=100 Evaluation of the iD-SystemTM, One-Handed Disposable Internal Defibrillation System.
Ventricular Fibrillation · Ventricular Tachycardia
Primary: Number of Patients With Skin Symptoms — 0 Participants
Phase 2 N=13 Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma
Mantle Cell Lymphoma
Primary: Stem Cell Mobilization Success Rate With Cytarabine and Rituximab — 4 Participants
Phase 4 N=25 Metformin for the Prevention of the Metabolic Side-effects of Zyprexa
Metabolic Complications
Primary: Weight Gain — 2.54; 5.88 kilogram